Cytta Competitors

OTC Stocks . USA . 
Stock . Cytta Corp
CYCA Stock  USD 0.02  0  10.56%   
Cytta Corp competes with Vislink Technologies, Scientific Industries, and ZTEST Electronics; as well as few others. The company conducts business under Health Care Technology sector and is part of Health Care industry. Analyzing Cytta Corp competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Cytta Corp to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Cytta Corp Correlation with its peers.

Cytta Corp vs ZTEST Electronics Correlation

Average diversification

The correlation between Cytta Corp and ZTSTF is 0.16 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Cytta Corp and ZTSTF in the same portfolio, assuming nothing else is changed.

Moving against Cytta OTC Stock

  0.63MSFT Microsoft Earnings Call This WeekPairCorr
  0.34SIGL Signal AdvancePairCorr
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cytta Corp's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.0250.83
Details
Intrinsic
Valuation
LowRealHigh
0.000.0150.82
Details
Naive
Forecast
LowNextHigh
0.00030.02126.88
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.010.010.02
Details

Cytta Corp Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Cytta Corp and its competitors represents the degree of relationship between the price movements of corresponding otcs. A correlation of about +1.0 implies that the price of Cytta and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Cytta Corp does not affect the price movement of the other competitor.

High positive correlations

ZTSTF
+ 0.6
VQSSF
TGCB
+ 0.58
VISL
PKKFF
+ 0.53
VISL
UCLE
+ 0.49
VISL
POSAF
+ 0.45
TGCB
UCLE
+ 0.43
SCND
  

High negative correlations

VQSSF
- 0.5
SCND
ZTSTF
- 0.48
SCND
PKKFF
- 0.41
VQSSF
ZTSTF
- 0.37
PKKFF
ZTSTF
- 0.33
UCLE
ZTSTF
- 0.29
VISL

Risk-Adjusted Indicators

There is a big difference between Cytta OTC Stock performing well and Cytta Corp OTC Stock doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Cytta Corp's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
VISL  5.41 (0.36) 0.00 (0.10) 0.00 
 0.00 
 12.90 
(10.47)
 35.25 
SCND  3.84 (0.02) 0.00  0.12  0.00 
 0.00 
 12.50 
(12.50)
 29.86 
VQSSF  2.28  0.21  0.01  4.05  3.26 
(9.64)
 8.33 
(7.14)
 22.62 
KPIFF  3.54 (0.15) 0.00 (0.08) 0.00 
 0.00 
 9.78 
(9.22)
 31.83 
UCLE  21.20  4.56  0.15  0.82  19.47 
(43.04)
 44.26 
(46.15)
 273.33 
TGCB  10.79  0.81  0.03 (0.28) 12.39 
(18.44)
 33.33 
(22.23)
 94.36 
POSAF  8.75  0.64  0.04 (5.92) 10.31 
(13.35)
 29.55 
(18.00)
 74.34 
PKKFF  20.71  2.97  0.11 (0.83) 20.26 
(31.20)
 56.52 
(39.24)
 118.59 
DRGV  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
ZTSTF  5.39  0.43  0.04  0.47  6.54 
(10.99)
 16.67 
(12.00)
 51.32 

Cytta Corp Competitive Analysis

The better you understand Cytta Corp competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Cytta Corp's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Cytta Corp's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
CYCA VISL SCND VQSSF KPIFF UCLE TGCB POSAF PKKFF DRGV
 10.56 
 0.02 
Cytta
 1.58 
 1.87 
Vislink
 11.54 
 0.58 
Scientific
 12.50 
 0.14 
VIQ
 5.71 
 0.03 
Edgewater
 20.00 
 0.06 
UCLE
 0.16 
 0.06 
Tego
 4.44 
 0.04 
POSaBIT
 0.20 
 0.05 
Tenet
 0.00 
 0.0002 
Dragon
Market Volatility
(90 Days Market Risk)
Out of control
Extremely Dangerous
Out of control
Out of control
Out of control
Out of control
Out of control
Out of control
Out of control
Very steady
Market Performance
(90 Days Performance)
Fair
Weakest
Weakest
Weak
Weak
Fair
Soft
Soft
Fair
Weakest
Odds of Financial Distress
(Probability Of Bankruptcy)
Strong
Risky
Low
Unknown
Small
Small
Low
Strong
Low
Strong
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Under Valued
Over Valued
Over Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Not Rated
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Current Ratio
3.61
7.68
9.16
N/A
0.12
0.78
1.74
1.59
4.97
5.97
Net Asset
911.01 K
44.99 M
29.03 M
N/A
406.74 K
2.85 M
529.34 K
7.9 M
195.29 M
9.85 M
Profit Margin
N/A
-0.27
-0.51
N/A
N/A
-0.52
N/A
-0.11
-0.56
-0.0612
EBITDA
(5 M)
(8.88 M)
(6.58 M)
N/A
(1.05 M)
(1.86 M)
(3.08 M)
(10.15 M)
(47.31 M)
522.83 K
Operating Margin
-829.72
-0.46
-0.66
N/A
-96.6
-0.55
N/A
-0.17
-0.12
0.0238
Current Valuation
34.94 M
(1.88 M)
31.32 M
N/A
6.96 M
3.72 M
13.41 M
100.74 M
59.35 M
1.78 M
Price To Book
26.57
0.19
1.51
N/A
N/A
9.53
51.71
10.85
0.65
N/A
Retained Earnings
(7.33 M)
(309.23 M)
3.36 M
N/A
N/A
(364 K)
N/A
N/A
N/A
N/A
Current Asset
20 K
N/A
5.35 M
N/A
N/A
1.25 M
N/A
N/A
N/A
N/A
Beta
0.73
1.27
0.34
N/A
2.04
-0.27
N/A
2.53
1.96
66.77
Number Of Employees
13
112
72
N/A
14
6
5
8
17
100
Shares Outstanding
383.69 M
2.46 M
7 M
N/A
187.24 M
30.16 M
27.32 M
138.42 M
99.54 M
2.05 B
Cash Flow From Operations
(2.38 M)
(9.75 M)
(5.51 M)
N/A
(1.42 M)
(441.03 K)
(1.62 M)
(2.19 M)
(40.89 M)
(198.78 K)
Total Debt
438.1 K
1.22 M
1.59 M
N/A
197.15 K
1.47 M
51.84 K
134.51 K
413.23 K
62 K
Return On Equity
-7.68
-0.24
-0.23
N/A
N/A
-19.46
-4.29
N/A
-0.54
0.0437
Z Score
-6.7
N/A
13.8
N/A
18.6
1.2
52.5
N/A
91.2
13.4
Return On Asset
-2.89
-0.14
-0.17
N/A
-0.83
-0.29
-1.99
-0.31
-0.0575
0.0266
Book Value Per Share
0.001
12.98
3.54
N/A
-0.011
-0.019
0.01
-0.017
1.36
0.017
Number Of Shares Shorted
N/A
36.72 K
N/A
N/A
N/A
N/A
N/A
N/A
335.85 K
N/A
Current Liabilities
460 K
N/A
1.42 M
N/A
N/A
723 K
N/A
N/A
N/A
N/A
Total Asset
911.01 K
44.99 M
29.03 M
N/A
406.74 K
2.85 M
529.34 K
7.9 M
195.29 M
9.85 M
Debt To Equity
N/A
0.046
0.064
N/A
487.7
2.06
0.032
13.7
0.015
0.008
Short Ratio
N/A
1.11
N/A
N/A
N/A
N/A
N/A
N/A
0.9
N/A
Target Price
N/A
9.0
N/A
N/A
N/A
N/A
N/A
N/A
2.55
N/A
Shares Owned By Institutions
N/A
20.81
17.72
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Market Capitalization
15.35 M
6.19 M
37.3 M
N/A
8.39 M
3.84 M
6.01 M
113.5 M
63.19 M
1.23 M
Price To Earning
-0.29
N/A
33.11
N/A
-6.84
-2.93
N/A
N/A
-6.13
-0.02
Price To Earnings To Growth
N/A
-0.26
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Price To Sales
1265.04
0.19
3.34
N/A
809.09
1.8
3924.33
3.45
0.5
0.0655
Net Income
(5.1 M)
(9.13 M)
(5.64 M)
N/A
(1.06 M)
(1.88 M)
(3.15 M)
(10.57 M)
(49.76 M)
58.48 K
Earnings Per Share
-0.013
-3.53
-0.84
N/A
-0.005
-0.068
-0.12
-0.088
-0.51
-0.004
Shares Owned By Insiders
29.32
9.9
46.47
N/A
2.37
37.8
26.22
36.27
7.53
N/A
Revenue
6.09 K
27.48 M
11.4 M
N/A
11.37 K
2.14 M
3.55 K
21.3 M
103.63 M
19.79 M
Working Capital
(440 K)
31.77 M
3.93 M
N/A
N/A
528 K
N/A
N/A
N/A
N/A
Cash And Equivalents
1.57 M
26.88 M
7.74 M
N/A
83.63 K
420.91 K
47.74 K
1.75 M
15.05 M
734.88 K
Cash Per Share
N/A
0.57
1.11
N/A
N/A
0.01
N/A
0.01
0.15
N/A
Gross Profit
6.09 K
16.44 M
5.74 M
N/A
10.21 K
1.38 M
3.55 K
5.54 M
8.69 M
1.23 M
Day Typical Price
0.0161
1.88
0.58
0.14
0.033
0.0567
0.0611
0.043
0.0499
2.0E-4
Accumulation Distribution
N/A
9.13
N/A
N/A
N/A
6024.67
N/A
N/A
N/A
N/A
Market Facilitation Index
N/A
1.0E-4
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Daily Balance Of Power
0
(1.00)
9.2 T
0
0
1.0
9.2 T
0
0
0.0
Period Momentum Indicator
(0)
(0.03)
0.06
(0.02)
(0)
0.01
1.0E-4
(0)
(0.0001)
N/A
Rate Of Daily Change
0.89
0.98
1.12
0.88
0.94
1.2
1.0
0.96
1.0
1.0
Day Median Price
0.0161
1.89
0.58
0.14
0.033
0.055
0.0611
0.043
0.0499
2.0E-4
Price Action Indicator
(0.0009)
(0.03)
0.03
(0.01)
(0)
0.01
1.0E-4
(0)
(0.00005)
N/A
Relative Strength Index
57.62
47.39
49.86
47.17
48.9
49.15
47.09
49.11
50.77
N/A
Coefficient Of Variation
742.95
(3,642)
(17,309)
2130.22
(8,127)
748.0
2607.5
2199.0
1009.01
N/A
Mean Deviation
34.76
5.41
3.84
2.28
3.54
21.2
10.79
8.75
20.71
N/A
Jensen Alpha
17.74
(0.36)
(0.02)
0.2065
(0.15)
4.56
0.8076
0.6371
2.97
N/A
Total Risk Alpha
4.8
(0.91)
(0.66)
(0.24)
(0.65)
1.37
(1.01)
(0.73)
0.0571
N/A
Sortino Ratio
1.19
N/A
N/A
0.0137
N/A
0.1483
0.031
0.0396
0.1052
N/A
Downside Variance
204.29
N/A
N/A
102.83
N/A
1101.3
344.92
198.48
642.83
N/A
Standard Deviation
126.86
7.22
6.37
4.69
5.84
37.42
17.11
14.06
27.73
N/A
Kurtosis
60.88
0.5888
1.42
3.78
2.4
19.58
2.28
2.84
0.0484
N/A
Potential Upside
29.17
12.9
12.5
8.33
9.78
44.26
33.33
29.55
56.52
N/A
Treynor Ratio
(1.80)
(0.1)
0.1184
4.05
(0.08)
0.8231
(0.28)
(5.92)
(0.83)
N/A
Maximum Drawdown
1030.43
35.25
29.86
22.62
31.83
273.33
94.36
74.34
118.59
N/A
Variance
16094.72
52.19
40.53
22.0
34.07
1400.59
292.69
197.76
769.05
N/A
Market Risk Adjusted Performance
(1.79)
(0.09)
0.1284
4.06
(0.07)
0.8331
(0.27)
(5.91)
(0.82)
N/A
Risk Adjusted Performance
0.1087
(0.01)
0.0046
0.0429
(0.0003)
0.1079
0.0377
0.0428
0.0825
N/A
Skewness
7.74
0.5588
0.1741
0.2884
0.5874
3.32
0.745
1.01
0.5238
N/A
Semi Deviation
8.65
N/A
N/A
3.26
N/A
19.47
12.39
10.31
20.26
N/A
Information Ratio
0.134
(0.04)
(0.02)
0.0297
(0.03)
0.1315
0.0336
0.0397
0.0962
N/A
Value At Risk
(23.08)
(10.47)
(12.50)
(7.14)
(9.22)
(46.15)
(22.23)
(18.00)
(39.24)
N/A
Expected Short fall
(56.84)
N/A
N/A
(9.64)
N/A
(43.04)
(18.44)
(13.35)
(31.20)
N/A
Downside Deviation
14.29
N/A
N/A
10.14
N/A
33.19
18.57
14.09
25.35
N/A
Semi Variance
74.76
N/A
N/A
10.6
N/A
379.05
153.45
106.22
410.55
N/A

Cytta Corp Competition Performance Charts

Five steps to successful analysis of Cytta Corp Competition

Cytta Corp's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Cytta Corp in relation to its competition. Cytta Corp's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Cytta Corp in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Cytta Corp's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Cytta Corp, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Cytta Corp position

In addition to having Cytta Corp in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Wireless Thematic Idea Now

Wireless
Wireless Theme
Companies providing wireless technology and communication services. The Wireless theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Wireless Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Cytta OTC Stock

Cytta Corp financial ratios help investors to determine whether Cytta OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cytta with respect to the benefits of owning Cytta Corp security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY